메뉴 건너뛰기




Volumn 47, Issue 6, 2014, Pages

Calibration of quality-adjusted life years for oncology clinical trials

Author keywords

Q TWiST; QALY; QOL; quality of life; quality adjusted life year; simulation

Indexed keywords

ARTICLE; CALIBRATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SIMULATION; ERROR; HAZARD RATIO; HUMAN; LOG RANK TEST; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; QUALITY ADJUSTED LIFE YEAR; RADIATION INJURY; RANK SUM TEST; SAMPLE SIZE; STATISTICAL SIGNIFICANCE; SURVIVAL; SURVIVAL TIME; TREATMENT DURATION; ALGORITHM; BIOLOGICAL MODEL; CLINICAL TRIAL (TOPIC); COMPUTER SIMULATION; LUNG NEOPLASMS; NEOPLASMS; PHASE 3 CLINICAL TRIAL (TOPIC); TIME;

EID: 84902463199     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2013.07.016     Document Type: Article
Times cited : (5)

References (15)
  • 1
    • 0024462761 scopus 로고
    • A quality-of-life-oriented endpoint for comparing therapies
    • R.D. Gelber, R.S. Gelman, and A. Goldhirsch A quality-of-life-oriented endpoint for comparing therapies Biometrics 45 1989 781 795
    • (1989) Biometrics , vol.45 , pp. 781-795
    • Gelber, R.D.1    Gelman, R.S.2    Goldhirsch, A.3
  • 2
    • 22544476793 scopus 로고    scopus 로고
    • The QALY model and individual preferences for health states and health profiles over time: A systematic review of literature
    • A. Tsuchiya, and P. Dolan The QALY model and individual preferences for health states and health profiles over time: a systematic review of literature Med Decis Making 25 2005 460 467
    • (2005) Med Decis Making , vol.25 , pp. 460-467
    • Tsuchiya, A.1    Dolan, P.2
  • 3
    • 33645101095 scopus 로고    scopus 로고
    • Analyzing oncology clinical trial data using the Q-TWiST method: Clinical importance and sources for health state preference data
    • D.A. Revicki, D. Feeny, T.L. Hunt, and B.F. Cole Analyzing oncology clinical trial data using the Q-TWiST method: clinical importance and sources for health state preference data Qual Life Res 15 2006 411 423
    • (2006) Qual Life Res , vol.15 , pp. 411-423
    • Revicki, D.A.1    Feeny, D.2    Hunt, T.L.3    Cole, B.F.4
  • 4
    • 0037252456 scopus 로고    scopus 로고
    • Model-based methodology for analyzing incomplete quality-of-life data and integrating them into the Q-TWiST framework
    • N. Mounier, C. Ferme, H. Flechtner, M. Henzy-Amar, and E. Lepage Model-based methodology for analyzing incomplete quality-of-life data and integrating them into the Q-TWiST framework Med Decis Making 23 2003 54 66
    • (2003) Med Decis Making , vol.23 , pp. 54-66
    • Mounier, N.1    Ferme, C.2    Flechtner, H.3    Henzy-Amar, M.4    Lepage, E.5
  • 5
    • 0036221470 scopus 로고    scopus 로고
    • A new graphic for quality adjusted life years (Q-TWiST) survival analysis: The Q-TWiST plot
    • J.A. Sloan, D.J. Sargent, and J. Lindman et al. A new graphic for quality adjusted life years (Q-TWiST) survival analysis: the Q-TWiST plot Qual Life Res 11 2002 37 45
    • (2002) Qual Life Res , vol.11 , pp. 37-45
    • Sloan, J.A.1    Sargent, D.J.2    Lindman, J.3
  • 6
    • 0037093059 scopus 로고    scopus 로고
    • Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: An updated decision analysis
    • V.R. Grann, J.S. Jacobson, and D. Thomason et al. Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis J Clin Oncol 20 2002 2520 2521
    • (2002) J Clin Oncol , vol.20 , pp. 2520-2521
    • Grann, V.R.1    Jacobson, J.S.2    Thomason, D.3
  • 7
    • 70349304187 scopus 로고    scopus 로고
    • Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: An analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 Trial
    • R.W. Jang, A. Le Maitre, and K. Ding et al. Quality-adjusted time without symptoms or toxicity analysis of adjuvant chemotherapy in non-small-cell lung cancer: an analysis of the National Cancer Institute of Canada Clinical Trials Group JBR.10 Trial J Clin Oncol 27 2009 4268 4273
    • (2009) J Clin Oncol , vol.27 , pp. 4268-4273
    • Jang, R.W.1    Le Maitre, A.2    Ding, K.3
  • 8
    • 67650503830 scopus 로고    scopus 로고
    • Long-term outcome and quality-adjusted life years after severe sepsis
    • Finnsepsis Study Group
    • S. Karlsson, E. Ruokonen, T. Varpula, T.I. Ala-Kokko, V. Pettila Finnsepsis Study Group Long-term outcome and quality-adjusted life years after severe sepsis Crit Care Med 37 2009 1268 1274
    • (2009) Crit Care Med , vol.37 , pp. 1268-1274
    • Karlsson, S.1    Ruokonen, E.2    Varpula, T.3    Ala-Kokko, T.I.4    Pettila, V.5
  • 9
    • 76149090862 scopus 로고    scopus 로고
    • Comparative effectiveness and health care spending - Implications for reform
    • M.C. Weinstein, and J.A. Skinner Comparative effectiveness and health care spending - implications for reform N Engl J Med 362 2010 460 465
    • (2010) N Engl J Med , vol.362 , pp. 460-465
    • Weinstein, M.C.1    Skinner, J.A.2
  • 11
    • 79960145633 scopus 로고    scopus 로고
    • Using QALYs in cancer: A review of the methodological limitations
    • M. Garau, K.K. Shah, and A.R. Mason et al. Using QALYs in cancer: a review of the methodological limitations Pharmacoeconomics 29 2011 673 685
    • (2011) Pharmacoeconomics , vol.29 , pp. 673-685
    • Garau, M.1    Shah, K.K.2    Mason, A.R.3
  • 12
    • 36048972049 scopus 로고    scopus 로고
    • Applying QOL assessments: Solution for oncology clinical practice and research, part 2
    • J.A. Sloan, A. Dueck, and M.H. Frost et al. Applying QOL assessments: solution for oncology clinical practice and research, part 2 Curr Probl Cancer 30 2006 235 331
    • (2006) Curr Probl Cancer , vol.30 , pp. 235-331
    • Sloan, J.A.1    Dueck, A.2    Frost, M.H.3
  • 13
    • 1542289007 scopus 로고    scopus 로고
    • A quality-adjusted survival (Q-TWiST) model for evaluating treatments for advanced cancer
    • B.F. Cole, R.D. Gelber, S. Gelber, and P. Mukhopadhyay A quality-adjusted survival (Q-TWiST) model for evaluating treatments for advanced cancer J Biopharm Stat 14 2004 111 124
    • (2004) J Biopharm Stat , vol.14 , pp. 111-124
    • Cole, B.F.1    Gelber, R.D.2    Gelber, S.3    Mukhopadhyay, P.4
  • 14
    • 77954631440 scopus 로고    scopus 로고
    • Quality-adjusted life-years, comparative effectiveness in cancer care, and measuring outcomes in the underserved
    • K.L. Kilbridge Quality-adjusted life-years, comparative effectiveness in cancer care, and measuring outcomes in the underserved Oncology 24 2010 530 537
    • (2010) Oncology , vol.24 , pp. 530-537
    • Kilbridge, K.L.1
  • 15
    • 0028872887 scopus 로고
    • Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2α in selected patients with malignant melanoma
    • E.T. Creagan, R.J. Dalton, and D.L. Ahmann et al. Randomized, surgical adjuvant clinical trial of recombinant interferon alfa-2α in selected patients with malignant melanoma J Clin Oncol 13 1995 2776 2783
    • (1995) J Clin Oncol , vol.13 , pp. 2776-2783
    • Creagan, E.T.1    Dalton, R.J.2    Ahmann, D.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.